{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T17:03:14Z","timestamp":1793120594845,"version":"4.5.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T00:00:00Z","timestamp":1748044800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Joint Fund of Science and Technology Innovation of Fujian Province","award":["2023Y9324"],"award-info":[{"award-number":["2023Y9324"]}]},{"name":"Joint Fund of Science and Technology Innovation of Fujian Province","award":["2021Y9024"],"award-info":[{"award-number":["2021Y9024"]}]},{"name":"Medical Vertical Project of Fujian Province","award":["2020CXB001"],"award-info":[{"award-number":["2020CXB001"]}]},{"name":"Key Project of Natural Science Foundation of Fujian Province","award":["2022J02048"],"award-info":[{"award-number":["2022J02048"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Virol J"],"DOI":"10.1186\/s12985-025-02737-3","type":"journal-article","created":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T03:46:27Z","timestamp":1748058387000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Immune evasion, infectivity, and membrane fusion of the SARS-CoV-2 JN.1 variant"],"prefix":"10.1186","volume":"22","author":[{"given":"Haijun","family":"Tang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanhang","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianlin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongzhao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinghua","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yisheng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minjian","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaonan","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueping","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenfeng","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,5,24]]},"reference":[{"issue":"7923","key":"2737_CR1","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao Y, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608(7923):593\u2013602. https:\/\/doi.org\/10.1038\/s41586-022-04980-y.","journal-title":"Nature."},{"key":"2737_CR2","doi-asserted-by":"publisher","first-page":"e70","DOI":"10.1016\/s1473-3099(23)00744-2","volume":"24","author":"S Yang","year":"2024","unstructured":"Yang S, et al. Fast evolution of SARS-CoV-2 BA.2.86 to JN.1 under heavy immune pressure. The Lancet Infectious diseases. 2024;24:e70\u20132. https:\/\/doi.org\/10.1016\/s1473-3099(23)00744-2.","journal-title":"The Lancet. Infectious diseases."},{"key":"2737_CR3","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/s41586-022-05053-w","volume":"608","author":"Q Wang","year":"2022","unstructured":"Wang Q, et al. Antibody evasion by SARS-CoV-2 Omicron subvariants\u00a0BA.2.12.1, BA.4 and BA.5. Nature. 2022;608:603\u20138. https:\/\/doi.org\/10.1038\/s41586-022-05053-w.","journal-title":"Nature."},{"key":"2737_CR4","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.cell.2023.12.026","volume":"187","author":"P Qu","year":"2024","unstructured":"Qu P, et al. Immune evasion, infectivity, and fusogenicity of SARS-CoV-2 BA.2.86 and FLip variants. Cell. 2024;187:585-595.e586. https:\/\/doi.org\/10.1016\/j.cell.2023.12.026.","journal-title":"Cell"},{"issue":"7","key":"2737_CR5","doi-asserted-by":"publisher","first-page":"e416","DOI":"10.1016\/s1473-3099(24)00298-6","volume":"24","author":"Y Kaku","year":"2024","unstructured":"Kaku Y, et al. Virological characteristics of the SARS-CoV-2 KP.2 variant. Lancet Infect Dis. 2024;24(7):e416. https:\/\/doi.org\/10.1016\/s1473-3099(24)00298-6.","journal-title":"Lancet Infect Dis."},{"key":"2737_CR6","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.medj.2024.03.006","volume":"5","author":"Q He","year":"2024","unstructured":"He Q, et al. Neutralization of EG.5, EG.5.1, BA.2.86, and JN.1 by antisera from dimeric receptor-binding domain subunit vaccines and 41 human monoclonal antibodies. Med (New York, NY). 2024;5:401-413.e404. https:\/\/doi.org\/10.1016\/j.medj.2024.03.006.","journal-title":"Med (New York, N.Y.)."},{"key":"2737_CR7","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1016\/j.cell.2023.12.025","volume":"187","author":"L Zhang","year":"2024","unstructured":"Zhang L, et al. SARS-CoV-2 BA.2.86 enters lung cells and evades neutralizing antibodies with high efficiency. Cell. 2024;187:596-608.e517. https:\/\/doi.org\/10.1016\/j.cell.2023.12.025.","journal-title":"Cell."},{"key":"2737_CR8","doi-asserted-by":"publisher","first-page":"2271089","DOI":"10.1080\/22221751.2023.2271089","volume":"12","author":"Y Hu","year":"2023","unstructured":"Hu Y, et al. Less neutralization evasion of SARS-CoV-2 BA.2.86 than XBB sublineages and CH.1.1. Emerg Microbes Infect. 2023;12:2271089. https:\/\/doi.org\/10.1080\/22221751.2023.2271089.","journal-title":"Emerg Microbes Infect."},{"key":"2737_CR9","doi-asserted-by":"publisher","first-page":"e82","DOI":"10.1016\/s1473-3099(23)00813-7","volume":"24","author":"Y Kaku","year":"2024","unstructured":"Kaku Y, et al. Virological characteristics of the SARS-CoV-2 JN.1 variant. Lancet Infect Dis. 2024;24:e82. https:\/\/doi.org\/10.1016\/s1473-3099(23)00813-7.","journal-title":"Lancet Infect Dis."},{"key":"2737_CR10","doi-asserted-by":"publisher","first-page":"e1011868","DOI":"10.1371\/journal.ppat.1011868","volume":"19","author":"F Jian","year":"2023","unstructured":"Jian F, et al. Convergent evolution of SARS-CoV-2 XBB lineages on receptor-binding domain 455\u2013456 synergistically enhances antibody evasion and ACE2 binding. PLoS Pathog. 2023;19:e1011868. https:\/\/doi.org\/10.1371\/journal.ppat.1011868.","journal-title":"PLoS Pathog"},{"key":"2737_CR11","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41392-022-00903-5","volume":"7","author":"X Du","year":"2022","unstructured":"Du X, et al. Omicron adopts a different strategy from Delta and other variants to adapt to host. Signal Transduct Target Ther. 2022;7:45. https:\/\/doi.org\/10.1038\/s41392-022-00903-5.","journal-title":"Signal Transduct Target Ther"},{"key":"2737_CR12","doi-asserted-by":"publisher","first-page":"706","DOI":"10.1038\/s41586-022-04474-x","volume":"603","author":"B Meng","year":"2022","unstructured":"Meng B, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts infectivity and fusogenicity. Nature. 2022;603:706\u201314. https:\/\/doi.org\/10.1038\/s41586-022-04474-x.","journal-title":"Nature"},{"key":"2737_CR13","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1038\/s41421-022-00431-0","volume":"8","author":"L Li","year":"2022","unstructured":"Li L, et al. Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s. Cell discovery. 2022;8:65. https:\/\/doi.org\/10.1038\/s41421-022-00431-0.","journal-title":"Cell discovery"},{"key":"2737_CR14","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1038\/s41421-020-00210-9","volume":"6","author":"L Wu","year":"2020","unstructured":"Wu L, et al. Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2. Cell discovery. 2020;6:68. https:\/\/doi.org\/10.1038\/s41421-020-00210-9.","journal-title":"Cell discovery"},{"key":"2737_CR15","doi-asserted-by":"publisher","first-page":"1518","DOI":"10.1016\/j.chom.2022.09.015","volume":"30","author":"P Qu","year":"2022","unstructured":"Qu P, et al. Evasion of neutralizing antibody responses by the SARS-CoV-2 BA.2.75 variant. Cell Host Microbe. 2022;30:1518-1526.e1514. https:\/\/doi.org\/10.1016\/j.chom.2022.09.015.","journal-title":"Cell Host Microbe"},{"key":"2737_CR16","doi-asserted-by":"publisher","first-page":"2270069","DOI":"10.1080\/22221751.2023.2270069","volume":"12","author":"JN Faraone","year":"2023","unstructured":"Faraone JN, et al. Immune evasion and membrane fusion of SARS-CoV-2 XBB subvariants\u00a0EG.5.1 and XBB.2.3. Emerg Microbes Infect. 2023;12:2270069. https:\/\/doi.org\/10.1080\/22221751.2023.2270069.","journal-title":"Emerg Microbes Infect."},{"key":"2737_CR17","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-022-05644-7","volume":"614","author":"Y Cao","year":"2023","unstructured":"Cao Y, et al. Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution. Nature. 2023;614:521\u20139. https:\/\/doi.org\/10.1038\/s41586-022-05644-7.","journal-title":"Nature"},{"key":"2737_CR18","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1038\/s41586-023-06750-w","volume":"624","author":"Q Wang","year":"2023","unstructured":"Wang Q, et al. Antigenicity and receptor affinity of SARS-CoV-2 BA.2.86 spike. Nature. 2023;624:639\u201344. https:\/\/doi.org\/10.1038\/s41586-023-06750-w.","journal-title":"Nature."},{"key":"2737_CR19","doi-asserted-by":"publisher","first-page":"6904","DOI":"10.1016\/j.vaccine.2023.10.051","volume":"41","author":"N Lasrado","year":"2023","unstructured":"Lasrado N, et al. Neutralization escape by SARS-CoV-2 Omicron subvariant\u00a0BA.2.86. Vaccine. 2023;41:6904\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2023.10.051.","journal-title":"Vaccine."},{"key":"2737_CR20","doi-asserted-by":"publisher","first-page":"8078","DOI":"10.1038\/s41467-023-43703-3","volume":"14","author":"K Khan","year":"2023","unstructured":"Khan K, et al. Evolution and neutralization escape of the SARS-CoV-2 BA.2.86 subvariant. Nat Commun. 2023;14:8078. https:\/\/doi.org\/10.1038\/s41467-023-43703-3.","journal-title":"Nat Commun."},{"key":"2737_CR21","doi-asserted-by":"publisher","first-page":"836232","DOI":"10.3389\/fimmu.2022.836232","volume":"13","author":"H Tang","year":"2022","unstructured":"Tang H, et al. Multiple SARS-CoV-2 Variants Exhibit Variable Target Cell Infectivity and Ability to Evade Antibody Neutralization. Front Immunol. 2022;13:836232. https:\/\/doi.org\/10.3389\/fimmu.2022.836232.","journal-title":"Front Immunol"},{"key":"2737_CR22","doi-asserted-by":"publisher","first-page":"110558","DOI":"10.1016\/j.celrep.2022.110558","volume":"38","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. Cross-species tropism and antigenic landscapes of circulating SARS-CoV-2 variants. Cell Rep. 2022;38:110558. https:\/\/doi.org\/10.1016\/j.celrep.2022.110558.","journal-title":"Cell Rep"},{"key":"2737_CR23","doi-asserted-by":"publisher","first-page":"1611","DOI":"10.1016\/j.immuni.2021.06.003","volume":"54","author":"R Wang","year":"2021","unstructured":"Wang R, et al. Analysis of SARS-CoV-2 variant mutations reveals neutralization escape mechanisms and the ability to use ACE2 receptors from additional species. Immunity. 2021;54:1611-1621.e1615. https:\/\/doi.org\/10.1016\/j.immuni.2021.06.003.","journal-title":"Immunity"},{"key":"2737_CR24","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/s41586-020-2012-7","volume":"579","author":"P Zhou","year":"2020","unstructured":"Zhou P, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579:270\u20133. https:\/\/doi.org\/10.1038\/s41586-020-2012-7.","journal-title":"Nature"},{"key":"2737_CR25","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41580-021-00418-x","volume":"23","author":"CB Jackson","year":"2022","unstructured":"Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23:3\u201320. https:\/\/doi.org\/10.1038\/s41580-021-00418-x.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2737_CR26","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1038\/s41586-022-04479-6","volume":"603","author":"KPY Hui","year":"2022","unstructured":"Hui KPY, et al. SARS-CoV-2 Omicron variant replication in human bronchus and lung ex vivo. Nature. 2022;603:715\u201320. https:\/\/doi.org\/10.1038\/s41586-022-04479-6.","journal-title":"Nature"},{"key":"2737_CR27","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s41586-022-04980-y","volume":"608","author":"Y Cao","year":"2022","unstructured":"Cao Y, et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature. 2022;608:593\u2013602. https:\/\/doi.org\/10.1038\/s41586-022-04980-y.","journal-title":"Nature."},{"key":"2737_CR28","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1038\/s41467-020-15562-9","volume":"11","author":"X Ou","year":"2020","unstructured":"Ou X, et al. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 2020;11:1620. https:\/\/doi.org\/10.1038\/s41467-020-15562-9.","journal-title":"Nat Commun"},{"key":"2737_CR29","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","volume":"181","author":"M Hoffmann","year":"2020","unstructured":"Hoffmann M, et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181:271-280.e278. https:\/\/doi.org\/10.1016\/j.cell.2020.02.052.","journal-title":"Cell"},{"key":"2737_CR30","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/s41586-020-2772-0","volume":"588","author":"DJ Benton","year":"2020","unstructured":"Benton DJ, et al. Receptor binding and priming of the spike protein of SARS-CoV-2 for membrane fusion. Nature. 2020;588:327\u201330. https:\/\/doi.org\/10.1038\/s41586-020-2772-0.","journal-title":"Nature"},{"key":"2737_CR31","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1126\/science.abc4730","volume":"369","author":"H Gu","year":"2020","unstructured":"Gu H, et al. Adaptation of SARS-CoV-2 in BALB\/c mice for testing vaccine efficacy. Science\u00a0(New York, NY). 2020;369:1603\u20137. https:\/\/doi.org\/10.1126\/science.abc4730.","journal-title":"Science\u00a0(New York, N.Y.)"},{"key":"2737_CR32","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.chom.2024.01.001","volume":"32","author":"T Tamura","year":"2024","unstructured":"Tamura T, et al. Virological characteristics of the SARS-CoV-2 BA.2.86 variant. Cell Host Microbe. 2024;32:170-180.e112. https:\/\/doi.org\/10.1016\/j.chom.2024.01.001.","journal-title":"Cell Host Microbe"},{"key":"2737_CR33","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1038\/s41586-024-07636-1","volume":"631","author":"B Dadonaite","year":"2024","unstructured":"Dadonaite B, et al. Spike deep mutational scanning helps predict success of SARS-CoV-2 clades. Nature. 2024;631:617\u201326. https:\/\/doi.org\/10.1038\/s41586-024-07636-1.","journal-title":"Nature"},{"key":"2737_CR34","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1038\/s41586-021-03412-7","volume":"593","author":"DA Collier","year":"2021","unstructured":"Collier DA, et al. Sensitivity of SARS-CoV-2 B.1.1.7 to mRNA vaccine-elicited antibodies. Nature. 2021;593:136\u201341. https:\/\/doi.org\/10.1038\/s41586-021-03412-7.","journal-title":"Nature."},{"key":"2737_CR35","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1126\/science.abn8652","volume":"375","author":"M McCallum","year":"2022","unstructured":"McCallum M, et al. Structural basis of SARS-CoV-2 Omicron immune evasion and receptor engagement. Science (New York, NY). 2022;375:864\u20138. https:\/\/doi.org\/10.1126\/science.abn8652.","journal-title":"Science (New York, N.Y.)."},{"key":"2737_CR36","doi-asserted-by":"publisher","first-page":"e0075124","DOI":"10.1128\/mbio.00751-24","volume":"15","author":"P Li","year":"2024","unstructured":"Li P, et al. Distinct patterns of SARS-CoV-2 BA.2.87.1 and JN.1 variants in immune evasion, antigenicity, and cell-cell fusion. mBio. 2024;15:e0075124-283. https:\/\/doi.org\/10.1128\/mbio.00751-24.","journal-title":"mBio"},{"key":"2737_CR37","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1080\/22221751.2021.2023329","volume":"11","author":"H Zhao","year":"2022","unstructured":"Zhao H, et al. SARS-CoV-2 Omicron variant shows less efficient replication and fusion activity when compared with Delta variant in TMPRSS2-expressed cells. Emerging microbes & infections. 2022;11:277\u201383. https:\/\/doi.org\/10.1080\/22221751.2021.2023329.","journal-title":"Emerging microbes & infections"},{"key":"2737_CR38","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1038\/s41392-022-00941-z","volume":"7","author":"Y Zhang","year":"2022","unstructured":"Zhang Y, et al. SARS-CoV-2 spike L452R mutation increases Omicron variant fusogenicity and infectivity as well as host glycolysis. Signal Transduct Target Ther. 2022;7:76. https:\/\/doi.org\/10.1038\/s41392-022-00941-z.","journal-title":"Signal Transduct Target Ther"},{"key":"2737_CR39","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1038\/s41586-021-04266-9","volume":"602","author":"A Saito","year":"2022","unstructured":"Saito A, et al. Enhanced fusogenicity and pathogenicity of SARS-CoV-2 Delta P681R mutation. Nature. 2022;602:300\u20136. https:\/\/doi.org\/10.1038\/s41586-021-04266-9.","journal-title":"Nature"},{"key":"2737_CR40","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1126\/science.abl9463","volume":"374","author":"J Zhang","year":"2021","unstructured":"Zhang J, et al. Membrane fusion and immune evasion by the spike protein of SARS-CoV-2 Delta variant. Science (New York, NY). 2021;374:1353\u201360. https:\/\/doi.org\/10.1126\/science.abl9463.","journal-title":"Science (New York, N.Y.)."},{"key":"2737_CR41","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1038\/s41421-023-00631-2","volume":"10","author":"L Wang","year":"2024","unstructured":"Wang L, et al. Fusogenicity of SARS-CoV-2 BA.2.86 subvariant and its sensitivity to the prokaryotic recombinant EK1 peptide. Cell Discov. 2024;10:6. https:\/\/doi.org\/10.1038\/s41421-023-00631-2.","journal-title":"Cell Discov."},{"key":"2737_CR42","doi-asserted-by":"publisher","first-page":"8728","DOI":"10.1038\/s41467-024-53033-7","volume":"15","author":"Y Liu","year":"2024","unstructured":"Liu Y, et al. Lineage-specific pathogenicity, immune evasion, and virological features of SARS-CoV-2 BA.2.86\/JN.1 and EG.5.1\/HK.3. Nat Commun. 2024;15:8728. https:\/\/doi.org\/10.1038\/s41467-024-53033-7.","journal-title":"Nat Commun."},{"key":"2737_CR43","doi-asserted-by":"publisher","first-page":"eabn8897","DOI":"10.1126\/science.abn8897","volume":"376","author":"T Zhou","year":"2022","unstructured":"Zhou T, et al. Structural basis for potent antibody neutralization of SARS-CoV-2 variants including B.1.1.529. Science (New York, NY). 2022;376:eabn8897. https:\/\/doi.org\/10.1126\/science.abn8897.","journal-title":"Science (New York, N.Y.)."},{"key":"2737_CR44","doi-asserted-by":"publisher","first-page":"e460","DOI":"10.1016\/s1473-3099(23)00575-3","volume":"23","author":"K Uriu","year":"2023","unstructured":"Uriu K, et al. Transmissibility, infectivity, and immune evasion of the SARS-CoV-2 BA.2.86 variant. Lancet Infect Dis. 2023;23:e460\u20131. https:\/\/doi.org\/10.1016\/s1473-3099(23)00575-3.","journal-title":"Lancet Infect Dis."}],"container-title":["Virology Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12985-025-02737-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12985-025-02737-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,24]],"date-time":"2025-05-24T03:46:29Z","timestamp":1748058389000},"score":1,"resource":{"primary":{"URL":"https:\/\/virologyj.biomedcentral.com\/articles\/10.1186\/s12985-025-02737-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,24]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["2737"],"URL":"https:\/\/doi.org\/10.1186\/s12985-025-02737-3","relation":{},"ISSN":["1743-422X"],"issn-type":[{"value":"1743-422X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,24]]},"assertion":[{"value":"19 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was performed in strict accordance with human subject protection guidance proved by the Research Ethics Committee of Fujian Provincial Hospital (number: K2023-03\u2013011).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent for publication was obtained from the patient.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"162"}}